CoreCap Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.16M | Sell |
17,047
-36
| -0.2% | -$6.68K | 0.13% | 153 |
|
|
2025
Q1 | $3.58M | Buy |
17,083
+725
| +4% | +$152K | 0.16% | 126 |
|
|
2024
Q4 | $2.91M | Buy |
16,358
+2,254
| +16% | +$401K | 0.13% | 149 |
|
|
2024
Q3 | $2.79M | Buy |
14,104
+752
| +6% | +$149K | 0.13% | 162 |
|
|
2024
Q2 | $2.29M | Buy |
13,352
+134
| +1% | +$23K | 0.24% | 86 |
|
|
2024
Q1 | $2.41M | Buy |
13,218
+651
| +5% | +$119K | 0.13% | 162 |
|
|
2023
Q4 | $1.95M | Buy |
12,567
+249
| +2% | +$38.6K | 0.13% | 168 |
|
|
2023
Q3 | $1.84M | Sell |
12,318
-11,786
| -49% | -$1.76M | 0.13% | 152 |
|
|
2023
Q2 | $3.25M | Buy |
+24,104
| New | +$3.25M | 0.23% | 86 |
|
|
2022
Q4 | $3.81M | Buy |
23,591
+2,178
| +10% | +$352K | 0.27% | 67 |
|
|
2022
Q3 | $2.87M | Buy |
21,413
+198
| +0.9% | +$26.6K | 0.24% | 75 |
|
|
2022
Q2 | $3.25M | Sell |
21,215
-855
| -4% | -$131K | 0.25% | 69 |
|
|
2022
Q1 | $3.58M | Buy |
22,070
+1,005
| +5% | +$163K | 0.25% | 72 |
|
|
2021
Q4 | $2.85M | Buy |
+21,065
| New | +$2.85M | 0.19% | 96 |
|